Interview: a conversation with Vishva M Dixit on his journey from remote African village to apoptosis, necroptosis and the inflammasome

Cell Death Differ. 2019 Mar;26(4):597-604. doi: 10.1038/s41418-019-0294-9.

Abstract

Vishva M. Dixit, M.D., Vice President of Physiological Chemistry at Genentech, Inc. has made many contributions to biomedicine, and his early work on apoptosis is prominent in introductory textbooks of biology and medicine.He is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and a Foreign Member, European Molecular Biology Organization.Additionally, he serves on the Boards of the Gates Foundation, Howard Hughes Medical Institute, and Keystone Symposia.

Publication types

  • Biography
  • Historical Article
  • Interview
  • Portrait

MeSH terms

  • Apoptosis / genetics*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Inflammasomes / genetics*
  • Inflammasomes / immunology
  • Inflammasomes / metabolism
  • Kenya
  • Necroptosis / genetics
  • Necroptosis / immunology
  • Public Health
  • Schools, Medical
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Thrombospondins
  • United States

Substances

  • Inflammasomes
  • Thrombospondins

Personal name as subject

  • Vishva M Dixit